TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
7 hedge funds and large institutions have $967K invested in TC BioPharm (Holdings) plc Warrants in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 7 → 7 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
69% less capital invested
Capital invested by funds: $3.17M → $967K (-$2.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$1.91K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$502 |
TCBPW Hedge Fund Activity: Q2 2022 in Review
7 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q2 2022, worth a combined $967K — down 69% from $3.17M a quarter earlier.
Fund positioning in TCBPW was balanced in Q2 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, adding an estimated $1.91K. The largest seller was Warberg Asset Management, cutting an estimated $502.
- 7 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $967K of TC BioPharm (Holdings) plc Warrants stock for Q2 2022, down 69% quarter-over-quarter.
- 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q2 2022 and 0 closed out.
- The largest TC BioPharm (Holdings) plc Warrants buyer in Q2 2022 was Virtu Financial, an estimated $1.91K added.
- The largest TC BioPharm (Holdings) plc Warrants seller in Q2 2022 was Warberg Asset Management, an estimated $502 sold.
Based on aggregated 13F filings for Q2 2022.